Dr. Talmon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 402-552-2512
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester) Surgical PathologyFellowship, Selective Pathology, 2007 - 2008
- University of Nebraska Medical Center College of MedicineResidency, Pathology-Anatomic and Clinical, 2003 - 2007
- University of Nebraska College of MedicineClass of 2003
Certifications & Licensure
- IA State Medical License 2015 - 2026
- NE State Medical License 2004 - 2026
- MN State Medical License 2007 - 2008
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- Mucin5AC promotes breast cancer brain metastasis through cMET/CD44v6.Shailendra Kumar Maurya, Jenny A Jaramillo-Gomez, Asad Ur Rehman, Shailendra Kumar Gautam, Mahek Fatima
Clinical Cancer Research. 2025-01-06 - Geranylgeranyl diphosphate synthase inhibition impairs osteoclast differentiation, morphology, and resorptive activity.Molly E Muehlebach, Staci L Haney, Yashpal S Chhonker, Mamunur Rashid, Daryl J Murry
JBMR Plus. 2025-01-01 - MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma.Kathryn M Muilenburg, Evie G Ehrhorn, Madeline T Olson, Carly C Isder, Kelsey A Klute
Cancers. 2024-10-10
Journal Articles
- Zyxin Promotes Colon Cancer Tumorigenesis in a Mitotic Phosphorylation-Dependent Manner and Through CDK8-Mediated YAP ActivationGeoffrey Talmon, MD, Proceedings of the National Academy of Sciences
Press Mentions
- Time Out with T.O. - Medical Education Icon to RetireDecember 16th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: